Search the Archive

A Closer Look (OxyContin) #739968

ABC Evening News for Friday, Oct 17, 2003
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Peter Jennings) A closer look at a prescription drug that has gained attention since radio talk show host Rush Limbaugh admitted an addiction to painkillers introduced.

(Studio: Brian Ross) Charges against the marketing practices of Purdue Pharma, the makers of the powerful pain reliever OxyContin that led to growing abuse of the drug, examined. [Two OxyContin misusers Virginia CHEERLEADER, celebrity rich KID - comment.] [Representative Frank WOLF - says a lot of people have been devastated.] [Former field rep Karen WHITE - talks about the company's sales practices.] The company's response to the abuse problem outlined.

Jennings, Peter;
Ross, Brian

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.